Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neurovent Research is a medical technology company specializing in advanced respiratory monitoring and neurally controlled mechanical ventilation. Founded by Dr. Christer Sinderby and Dr. Jennifer Beck, the company is the primary developer of Neurally Adjusted Ventilatory Assist (NAVA) technology, which uses the electrical activity of the diaphragm (Edi) to synchronize ventilator support with a patient's neural respiratory drive. This technology is designed to improve patient-ventilator interaction, reduce the work of breathing, and facilitate weaning in both adult and neonatal intensive care settings. Neurovent Research continues to innovate in the field of diaphragm electromyography (EMG) and respiratory monitoring, maintaining a long-standing commercial partnership with Getinge (formerly Maquet) for the global distribution of NAVA-enabled ventilators.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinderby.